Status:
COMPLETED
Deceased Donor Biomarkers and Recipient Outcomes
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Johns Hopkins University
Conditions:
Deceased Donor Kidney Transplant
Acute Kidney Injury
Eligibility:
All Genders
Brief Summary
Compared to chronic dialysis, kidney transplantation provides recipients with longer survival and better quality of life at a lower cost. In order to meet increasing demands for kidney allografts, kid...
Detailed Description
Our study has several key processes that we have developed and tested to address our scientific aims: 1. Enrollment We will collect urine samples from approximately 1600 deceased donors and appro...
Eligibility Criteria
Inclusion
- Donor Cohort: Appropriate informed consent for research according to OPO policies
- Recipient Cohorts: Any recipient of at least one kidney from a deceased donor enrolled by our participating OPOs
Exclusion
- • Donor Cohort: Lack of adequate biospecimen quantity or quality as per protocol
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
1679 Patients enrolled
Trial Details
Trial ID
NCT01848249
Start Date
May 1 2010
End Date
March 1 2020
Last Update
April 9 2020
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale New Haven Hospital
New Haven, Connecticut, United States, 06510
2
University of Maryland Medical Center
Baltimore, Maryland, United States, 21201
3
New England Organ Bank
Waltham, Massachusetts, United States, 02451
4
Gift of Life Michigan
Ann Arbor, Michigan, United States, 48108